Early response and local control of stage I non-small-cell lung cancer after stereotactic radiotherapy: Difference by histology

Cancer Science

Volumn 104, Issue 1, 2013, Pages 130-134

  Miyakawa, Akifumi ^a   Shibamoto, Yuta ^a   Kosaki, Katsura ^a   Hashizume, Chisa ^b  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Nagoya Kyoritsu Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT RESPONSE; TUMOR VOLUME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOSURGERY; RADIOTHERAPY DOSAGE; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 84872267385     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12048     Document Type: Article

References (27)

1. Barillot I, Horriot JC, Pigneux J et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostic factors. Int J Radiat Oncol Biol Phys 1997; 38: 969-78.
2. Yalman D, Aras AB, Ozkök S et al. Prognostic factors in definitive radiotherapy of uterine cervical cancer. Eur J Gynaecol Oncol 2003; 24: 309-14.
3. Munzenrider JE. Recent advances in radiotherapy. Rev Interam Radiol 1977; 2: 123-33.
4. Milsom I, Friberg LG. Primary adenocarcinoma of the uterine cervix. A clinical study. Cancer 1983; 52: 942-7.
5. Stanley JA, Shipley WU, Steel GG. Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour. Br J Cancer 1977; 36: 105-13.
6. Shibamoto Y, Yukawa Y, Tsutsui K, Takahashi M, Abe M. Variation in the hypoxic fraction among mouse tumors of different types, sizes, and sites. Jpn J Cancer Res 1986; 77: 908-15.
7. Overgaard J, Hansen HS, Andersen AP et al. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study. Int J Radiat Oncol Biol Phys 1989; 16: 1065-8.
8. Grogan M, Thomas GM, Melamed I et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999; 86: 1528-36.
9. Henke M, Sindlinger F, Ikenberg H, Gerds T, Schumacher M. Blood hemoglobin level and treatment outcome of early breast cancer. Strahlenther Onkol 2004; 180: 45-51.
10. Hoff CM, Hansen HS, Overgaard M et al. The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy: results from the randomized DAHANCA 5 study. Radiother Oncol 2011; 98: 23-33.
11. Mortensen LS, Busk M, Nordmark M et al. Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study. Radiother Oncol 2011; 99: 418-23.
12. Uematsu M, Shioda A, Suda A et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small-cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 2001; 51: 666-70.
13. Onishi H, Kuriyama K, Komiyama T et al. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer 2004; 45: 45-55.
14. Nagata Y, Wulf J, Lax I et al. Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys 2011; 79: 660-9.
15. Kosaki K, Shibamoto Y, Hirai T et al. Regression curves of brain metastases after gamma knife irradiation: difference by tumor and patient characteristics. Cancer Sci 2012; 103: 1967-73.
16. Baba F, Shibamoto Y, Ogino H et al. Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size. Radiat Oncol 2010; 5: 81.
17. Shibamoto Y, Hashizume C, Baba F et al. Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study. Cancer 2012; 118: 2078-84.
18. Sobin LH, Gospodarowicz MK, Wittekind C, eds. TNM Classification of Maligant Tumors, 7th edn. (UICC International Union Against Cancer). New York: Wiley-Blackwell, 2009.
19. Watanabe H, Kanamori I, Ohno K et al. Tumor biology. In: Watanabe H, Kanamori I, eds. Introduction to Radiotherapy, 2nd edn. Tokyo: Iryo Kagaku Sha, 2008; 1-30 [in Japanese].
20. Tsukahara Y, Sakai Y, Noguchi H, Iwai S, Fukuta T. A study on radiosensitivity and prognostic factors of cervical adenocarcinoma. Acta Obst Gynaec Jpn 1980; 32: 1609-14.
21. Shibamoto Y, Shibata T, Miyatake S et al. Assessment of the proliferative activity and radiosensitivity of human tumours using the cytokinesis-block micronucleus assay. Br J Cancer 1994; 70: 67-71.
22. West CM, Davidson SE, Burt PA, Hunter RD. The intrinsic radiosensitivity of cervical carcinoma: correlations with clinical data. Int J Radiat Oncol Biol Phys 1995; 31: 841-6.
23. Shibamoto Y, Ike O, Mizuno H, Fukase T, Hitomi S, Takahashi M. Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome. Clin Cancer Res 1998; 4: 677-82.
24. Takeda A, Kunieda E, Ohashi T, Aoki Y, Koike N, Takeda T. Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer. Radiother Oncol 2011; 101: 255-9.
25. Iwata H, Murai T, Shibamoto Y. Radiation response of the normal lung tissue and lung tumors. In: Jeremic B, ed. Advances in Radiation Oncology in Lung Cancer, 2nd edn. Berlin Heidelberg: Springer-Verlag, 2011; 119-28.
26. Shibamoto Y, Kitakabu Y, Murata R et al. Reoxygenation in the SCCVII tumor after KU-2285 sensitization plus single or fractionated irradiation. Int J Radiat Oncol Biol Phys 1994; 29: 583-6.
27. Murata R, Shibamoto Y, Sasai K et al. Reoxygenation after single irradiation in rodent tumors of different types and sizes. Int J Radiat Oncol Biol Phys 1996; 34: 859-65.